Symbol:
Cldn15
Name:
claudin 15
RGD ID:
1310678
Description:
Predicted to enable paracellular tight junction channel activity. Predicted to be involved in several processes, including bicellular tight junction assembly; paracellular transport; and regulation of intestinal absorption. Predicted to be located in lateral plasma membrane and tight junction. Predicted to be active in bicellular tight junction and plasma membrane. Orthologous to human CLDN15 (claudin 15); PARTICIPATES IN hepatitis C pathway; INTERACTS WITH 2,2',4,4'-Tetrabromodiphenyl ether; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
claudin-15; LOC304388
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CLDN15 (claudin 15)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Cldn15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Cldn15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CLDN15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CLDN15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Cldn15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CLDN15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CLDN15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Cldn15 (claudin 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
CLDN15 (claudin 15)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Cldn15 (claudin 15)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cldn15b (claudin 15b)
Alliance
DIOPT (InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cldn15a (claudin 15a)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
cldn15.2
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoInspector)
Xenopus tropicalis (tropical clawed frog):
cldn15.1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 25,334,849 - 25,345,104 (-) NCBI GRCr8 mRatBN7.2 12 19,698,167 - 19,708,419 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 19,698,337 - 19,706,819 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 20,837,753 - 20,845,310 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 21,450,458 - 21,458,015 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 20,515,654 - 20,523,070 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 22,738,198 - 22,750,392 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 22,738,195 - 22,748,860 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 24,749,982 - 24,759,973 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 20,823,334 - 20,845,306 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 20,813,183 - 20,833,795 (+) NCBI Celera 12 21,475,263 - 21,482,160 (-) NCBI Celera Cytogenetic Map 12 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cldn15 Rat 1,2-dimethylhydrazine multiple interactions ISO Cldn15 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLDN15 mRNA CTD PMID:22206623 Cldn15 Rat 1-Hydroxypyrene decreases expression ISO CLDN15 (Homo sapiens) 6480464 1-hydroxypyrene results in decreased expression of CLDN15 mRNA CTD PMID:21854004 Cldn15 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 Cldn15 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cldn15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CLDN15 mRNA CTD PMID:19770486 Cldn15 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLDN15 mRNA CTD PMID:33387578 Cldn15 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN15 mRNA CTD PMID:34747641 Cldn15 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cldn15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLDN15 mRNA CTD PMID:27913140 Cldn15 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CLDN15 mRNA CTD PMID:22808131 Cldn15 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cldn15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN15 mRNA CTD PMID:21570461 Cldn15 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Cldn15 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Cldn15 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CLDN15 mRNA CTD PMID:36041667 Cldn15 Rat 4-hydroxyphenyl retinamide decreases expression ISO Cldn15 (Mus musculus) 6480464 Fenretinide results in decreased expression of CLDN15 mRNA CTD PMID:28973697 Cldn15 Rat acrylamide increases expression ISO CLDN15 (Homo sapiens) 6480464 Acrylamide results in increased expression of CLDN15 mRNA CTD PMID:32763439 Cldn15 Rat aristolochic acid A increases expression ISO CLDN15 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CLDN15 mRNA CTD PMID:33212167 Cldn15 Rat atrazine decreases expression ISO CLDN15 (Homo sapiens) 6480464 Atrazine results in decreased expression of CLDN15 mRNA CTD PMID:22378314 Cldn15 Rat benzo[a]pyrene multiple interactions ISO Cldn15 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CLDN15 mRNA] CTD PMID:22228805 Cldn15 Rat benzo[a]pyrene affects methylation ISO CLDN15 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CLDN15 polyA tail CTD PMID:30157460 Cldn15 Rat benzo[a]pyrene increases expression ISO Cldn15 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CLDN15 mRNA CTD PMID:22228805 Cldn15 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLDN15 mRNA CTD PMID:25181051 Cldn15 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CLDN15 mRNA CTD PMID:36041667 Cldn15 Rat bisphenol A increases expression ISO Cldn15 (Mus musculus) 6480464 bisphenol A results in increased expression of CLDN15 mRNA CTD PMID:32156529 Cldn15 Rat bisphenol A multiple interactions ISO CLDN15 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLDN15 gene CTD PMID:31601247 Cldn15 Rat bisphenol A decreases methylation ISO CLDN15 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of CLDN15 gene CTD PMID:31601247 Cldn15 Rat bisphenol A decreases methylation ISO Cldn15 (Mus musculus) 6480464 bisphenol A results in decreased methylation of CLDN15 promoter CTD PMID:27312807 Cldn15 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CLDN15 mRNA CTD PMID:36041667 Cldn15 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CLDN15 mRNA CTD PMID:19167457 Cldn15 Rat carbon nanotube decreases expression ISO Cldn15 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Cldn15 Rat chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of CLDN15 mRNA CTD PMID:23125180 Cldn15 Rat chromium(6+) multiple interactions ISO CLDN15 (Homo sapiens) 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CLDN15 mRNA CTD PMID:38479592 Cldn15 Rat copper atom multiple interactions ISO CLDN15 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of CLDN15 mRNA CTD PMID:20971185 Cldn15 Rat copper(0) multiple interactions ISO CLDN15 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of CLDN15 mRNA CTD PMID:20971185 Cldn15 Rat cytarabine decreases expression ISO CLDN15 (Homo sapiens) 6480464 Cytarabine results in decreased expression of CLDN15 mRNA CTD PMID:21198554 Cldn15 Rat DDE decreases expression ISO CLDN15 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of CLDN15 mRNA CTD PMID:38568856 Cldn15 Rat Dibutyl phosphate affects expression ISO CLDN15 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of CLDN15 mRNA CTD PMID:37042841 Cldn15 Rat folic acid multiple interactions ISO Cldn15 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLDN15 mRNA CTD PMID:22206623 Cldn15 Rat fulvestrant multiple interactions ISO CLDN15 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLDN15 gene CTD PMID:31601247 Cldn15 Rat genistein increases expression ISO Cldn15 (Mus musculus) 6480464 Genistein results in increased expression of CLDN15 mRNA CTD PMID:32186404 Cldn15 Rat iron dichloride decreases expression ISO CLDN15 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of CLDN15 mRNA CTD PMID:35984750 Cldn15 Rat lithium chloride decreases expression ISO Cldn15 (Mus musculus) 6480464 Lithium Chloride results in decreased expression of CLDN15 mRNA and Lithium Chloride results in decreased expression of CLDN15 protein CTD PMID:33901603 Cldn15 Rat N-nitrosodiethylamine multiple interactions ISO Cldn15 (Mus musculus) 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CLDN15 gene CTD PMID:23968726 Cldn15 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of CLDN15 mRNA CTD PMID:33484710 Cldn15 Rat ozone multiple interactions ISO Cldn15 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CLDN15 mRNA CTD PMID:34911549 Cldn15 Rat paracetamol affects expression ISO Cldn15 (Mus musculus) 6480464 Acetaminophen affects the expression of CLDN15 mRNA CTD PMID:17562736 Cldn15 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CLDN15 mRNA CTD PMID:33387578 Cldn15 Rat piperonyl butoxide multiple interactions ISO Cldn15 (Mus musculus) 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CLDN15 gene CTD PMID:23968726 Cldn15 Rat pirinixic acid decreases expression ISO Cldn15 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CLDN15 mRNA CTD PMID:17426115 Cldn15 Rat resveratrol multiple interactions ISO CLDN15 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN15 mRNA CTD PMID:23557933 Cldn15 Rat silver atom increases expression ISO Cldn15 (Mus musculus) 6480464 Silver results in increased expression of CLDN15 mRNA CTD PMID:27131904 Cldn15 Rat silver(0) increases expression ISO Cldn15 (Mus musculus) 6480464 Silver results in increased expression of CLDN15 mRNA CTD PMID:27131904 Cldn15 Rat sodium arsenite increases expression ISO CLDN15 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CLDN15 mRNA CTD PMID:38568856 Cldn15 Rat tetracycline decreases expression ISO CLDN15 (Homo sapiens) 6480464 Tetracycline results in decreased expression of CLDN15 mRNA CTD PMID:28882639 Cldn15 Rat thiram increases expression ISO CLDN15 (Homo sapiens) 6480464 Thiram results in increased expression of CLDN15 mRNA CTD PMID:38568856 Cldn15 Rat titanium dioxide affects expression ISO Cldn15 (Mus musculus) 6480464 titanium dioxide affects the expression of CLDN15 mRNA CTD PMID:23557971 Cldn15 Rat tributylstannane increases expression ISO Cldn15 (Mus musculus) 6480464 tributyltin results in increased expression of CLDN15 mRNA CTD PMID:31939706 Cldn15 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CLDN15 mRNA CTD PMID:33387578 Cldn15 Rat triclosan increases expression ISO CLDN15 (Homo sapiens) 6480464 Triclosan results in increased expression of CLDN15 mRNA CTD PMID:30510588 Cldn15 Rat trimellitic anhydride increases expression ISO Cldn15 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CLDN15 mRNA CTD PMID:19042947 Cldn15 Rat triphenyl phosphate affects expression ISO CLDN15 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CLDN15 mRNA CTD PMID:37042841 Cldn15 Rat triptonide affects expression ISO Cldn15 (Mus musculus) 6480464 triptonide affects the expression of CLDN15 mRNA CTD PMID:33045310 Cldn15 Rat valproic acid increases methylation ISO CLDN15 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CLDN15 gene CTD PMID:29154799
Imported Annotations - KEGG (archival)
1,2-dimethylhydrazine (ISO) 1-Hydroxypyrene (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 4,4'-sulfonyldiphenol (EXP) 4-hydroxyphenyl retinamide (ISO) acrylamide (ISO) aristolochic acid A (ISO) atrazine (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP) C60 fullerene (EXP) carbon nanotube (ISO) chloroprene (EXP) chromium(6+) (ISO) copper atom (ISO) copper(0) (ISO) cytarabine (ISO) DDE (ISO) Dibutyl phosphate (ISO) folic acid (ISO) fulvestrant (ISO) genistein (ISO) iron dichloride (ISO) lithium chloride (ISO) N-nitrosodiethylamine (ISO) nitrofen (EXP) ozone (ISO) paracetamol (EXP,ISO) piperonyl butoxide (ISO) pirinixic acid (ISO) resveratrol (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) tetracycline (ISO) thiram (ISO) titanium dioxide (ISO) tributylstannane (ISO) trichloroethene (EXP) triclosan (ISO) trimellitic anhydride (ISO) triphenyl phosphate (ISO) triptonide (ISO) valproic acid (ISO)
Cldn15 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 25,334,849 - 25,345,104 (-) NCBI GRCr8 mRatBN7.2 12 19,698,167 - 19,708,419 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 19,698,337 - 19,706,819 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 20,837,753 - 20,845,310 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 21,450,458 - 21,458,015 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 20,515,654 - 20,523,070 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 22,738,198 - 22,750,392 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 22,738,195 - 22,748,860 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 24,749,982 - 24,759,973 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 20,823,334 - 20,845,306 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 20,813,183 - 20,833,795 (+) NCBI Celera 12 21,475,263 - 21,482,160 (-) NCBI Celera Cytogenetic Map 12 q12 NCBI
CLDN15 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 101,232,094 - 101,238,820 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 101,232,092 - 101,238,820 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 100,875,375 - 100,882,101 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 100,662,094 - 100,667,836 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 7 100,470,513 - 100,474,466 NCBI Celera 7 95,884,531 - 95,891,259 (-) NCBI Celera Cytogenetic Map 7 q22.1 NCBI HuRef 7 95,468,416 - 95,475,144 (-) NCBI HuRef CHM1_1 7 100,805,777 - 100,812,511 (-) NCBI CHM1_1 T2T-CHM13v2.0 7 102,555,557 - 102,562,283 (-) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 100,233,760 - 100,240,488 (-) NCBI
Cldn15 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 136,996,723 - 137,004,699 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 136,995,470 - 137,004,712 (+) Ensembl GRCm39 Ensembl GRCm38 5 136,967,869 - 136,975,845 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 136,966,616 - 136,975,858 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 137,443,739 - 137,451,710 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 137,252,496 - 137,260,467 (+) NCBI MGSCv36 mm8 Celera 5 133,983,919 - 133,991,861 (+) NCBI Celera Cytogenetic Map 5 G2 NCBI cM Map 5 76.07 NCBI
Cldn15 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955456 16,062,046 - 16,069,540 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955456 16,062,044 - 16,067,612 (+) NCBI ChiLan1.0 ChiLan1.0
CLDN15 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 6 119,245,327 - 119,252,795 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 7 167,509,956 - 167,517,417 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 7 93,373,450 - 93,380,912 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 7 106,613,604 - 106,620,479 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 7 106,613,604 - 106,620,479 (-) Ensembl panpan1.1 panPan2
CLDN15 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 6 8,647,372 - 8,651,869 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 6 8,647,712 - 8,652,650 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 6 10,343,322 - 10,350,444 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 6 8,465,464 - 8,472,596 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 6 8,467,446 - 8,472,412 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 6 8,421,233 - 8,428,357 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 6 8,396,279 - 8,403,428 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 6 8,560,953 - 8,568,037 (+) NCBI UU_Cfam_GSD_1.0
Cldn15 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409344 132,923,926 - 132,929,684 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936543 1,106,635 - 1,111,140 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936543 1,106,846 - 1,112,669 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CLDN15 (Sus scrofa - pig)
CLDN15 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 28 11,940,318 - 11,947,811 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 28 11,942,271 - 11,947,627 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666070 4,405,099 - 4,412,551 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cldn15 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 46 Count of miRNA genes: 45 Interacting mature miRNAs: 45 Transcripts: ENSRNOT00000001923 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631560 Apr1 Acute phase response QTL 1 6.1 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 19144362 46669029 Rat 61443 Btemp2 Thermal response to stress QTL 2 3.3 0.000094 body temperature trait (VT:0005535) core body temperature (CMO:0001036) 12 15025183 20794014 Rat 8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 3.5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 61324 Eae5 Experimental allergic encephalomyelitis QTL 5 14 nervous system integrity trait (VT:0010566) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402) 12 19610870 46669029 Rat 9590147 Scort7 Serum corticosterone level QTL 7 13.61 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 12 1 42110980 Rat 1549829 Scl48 Serum cholesterol level QTL 48 5 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 12 9603277 46669029 Rat 61331 Eau2 Experimental allergic uveoretinitis QTL 2 0.0005 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 12 8525423 28064601 Rat 737822 Alc10 Alcohol consumption QTL 10 2.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 19610870 40218516 Rat 2293684 Bmd26 Bone mineral density QTL 26 4.4 0.0002 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 12 15872653 32974238 Rat 6893681 Bw109 Body weight QTL 109 2.3 0.004 body mass (VT:0001259) body weight (CMO:0000012) 12 1 23297788 Rat 1302792 Scl21 Serum cholesterol level QTL 21 3.8 0.0011 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 12 7196730 46669029 Rat 1598855 Bp294 Blood pressure QTL 294 3.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 1 34851688 Rat 10755457 Coatc14 Coat color QTL 14 0.01759 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 12 1 22591684 Rat 1331761 Bp218 Blood pressure QTL 218 2.973 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 45055165 Rat 8694179 Bw150 Body weight QTL 150 2.9 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411545 Bw128 Body weight QTL 128 5.2 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411547 Bw129 Body weight QTL 129 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 5564495 46669029 Rat 1300157 Rf21 Renal function QTL 21 4.4 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 12 9318216 32103380 Rat 737979 Pia22 Pristane induced arthritis QTL 22 53.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 1 44465750 Rat 1298081 Cia25 Collagen induced arthritis QTL 25 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610889 35682913 Rat 2300186 Bmd59 Bone mineral density QTL 59 7.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 12 10474137 46669029 Rat 7411660 Foco28 Food consumption QTL 28 10.9 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 1331755 Bp219 Blood pressure QTL 219 3.041 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 28064557 Rat 2306789 Ean6 Experimental allergic neuritis QTL 6 4.9 nervous system integrity trait (VT:0010566) experimental autoimmune neuritis severity score (CMO:0001528) 12 19610870 24139202 Rat 7411641 Foco19 Food consumption QTL 19 27.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 5684888 Pia42 Pristane induced arthritis QTL 42 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610870 42828880 Rat 1549912 Bp268 Blood pressure QTL 268 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 13182736 46669029 Rat 2302060 Pia37 Pristane induced arthritis QTL 37 6.1 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 13198157 46669029 Rat 1641928 Alcrsp5 Alcohol response QTL 5 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 12 12812385 46669029 Rat 8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564498 46669029 Rat 10059594 Kidm46 Kidney mass QTL 46 3.79 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 12 6107579 46669029 Rat 1581516 Cm56 Cardiac mass QTL 56 4.2 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 12 1 29333307 Rat 9590086 Insglur6 Insulin/glucose ratio QTL 6 18.97 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 12 1 42110980 Rat 8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 1549902 Bp269 Blood pressure QTL 269 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 13182736 46669029 Rat 61404 Bw120 Body weight QTL 120 5.1 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 12 12351619 46669029 Rat 1331786 Kidm11 Kidney mass QTL 11 3.571 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 12 11073825 24234895 Rat 2293699 Bss49 Bone structure and strength QTL 49 5.61 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 12 10474137 46669029 Rat 634351 Apr5 Acute phase response QTL 5 6.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 12 1 44503507 Rat 634350 Apr4 Acute phase response QTL 4 6 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 1172005 46172005 Rat 61416 Pia4 Pristane induced arthritis QTL 4 8.4 joint integrity trait (VT:0010548) arthritic paw count (CMO:0001460) 12 13635523 30827399 Rat 7387292 Kidm42 Kidney mass QTL 42 3.03 0.0004 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 12 1 36247923 Rat 61421 Cia12 Collagen induced arthritis QTL 12 4.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 13635523 35682913 Rat 2303569 Gluco44 Glucose level QTL 44 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 12812385 46669029 Rat 7411586 Foco5 Food consumption QTL 5 5.4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 2303575 Insul14 Insulin level QTL 14 4 blood insulin amount (VT:0001560) blood insulin level (CMO:0000349) 12 1 42450532 Rat 7411588 Foco6 Food consumption QTL 6 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2302042 Pia38 Pristane induced arthritis QTL 38 3.5 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 1 44503507 Rat 7411595 Foco9 Food consumption QTL 9 4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 7411597 Foco10 Food consumption QTL 10 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2293086 Iddm30 Insulin dependent diabetes mellitus QTL 30 3.82 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 8449490 28302290 Rat 631543 Bp83 Blood pressure QTL 83 5.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 15550826 38478808 Rat
RH142325
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 19,708,602 - 19,708,801 (+) MAPPER mRatBN7.2 Rnor_6.0 12 22,750,530 - 22,750,728 NCBI Rnor6.0 Rnor_5.0 12 24,760,096 - 24,760,294 UniSTS Rnor5.0 RGSC_v3.4 12 20,821,523 - 20,821,721 UniSTS RGSC3.4 Celera 12 21,484,028 - 21,484,226 UniSTS RH 3.4 Map 12 277.7 UniSTS Cytogenetic Map 12 q12 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000001923 ⟹ ENSRNOP00000001923
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 19,698,337 - 19,706,819 (-) Ensembl Rnor_6.0 Ensembl 12 22,738,195 - 22,748,860 (-) Ensembl
RefSeq Acc Id:
NM_001107135 ⟹ NP_001100605
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 25,334,849 - 25,343,625 (-) NCBI mRatBN7.2 12 19,698,167 - 19,706,946 (-) NCBI Rnor_6.0 12 22,739,324 - 22,748,662 (-) NCBI Rnor_5.0 12 24,749,982 - 24,759,973 (-) NCBI RGSC_v3.4 12 20,823,334 - 20,845,306 (+) RGD Celera 12 21,475,263 - 21,482,160 (-) NCBI
Sequence:
ATGTCGATAGCTGTGGAGACCTTTGGTTTCTTCATGTCAGCCCTGGGACTGCTGATGCTGGGGGTGACCCTTCCAAACAGCTACTGGAGAGTGTCTACCGTCCATGGGAACGTCATCACCACTAACAC CATCTTCGAGAACCTGTGGTACAGCTGTGCCACCGACTCCCTGGGAGTCTCCAACTGCTGGGACTTCCCGTCCATGCTGGCCCTCTCTGGCTATGTCCAGGGCTGCCGAGCTCTCATGATCACCGCCA TCCTCCTGGGCTTCCTGGGCCTCTTTCTAGGCATGGTGGGGCTCCGCTGCACCAACGTGGGCAACATCGACCTCTCCAGAAAGGCCAAGCTGCTGGCCATTGCAGGGGCCTTCCACATACTTGCTGGA GCCTGTGGCATGGTTGCTATCTCATGGTATGCTGTCAACATCACCACCGACTTCTTCAACCCCCTGTATGTTGGAACCAAGTATGAACTGGGCTCTGCCCTCTACTTGGGCTGGAGCGCCTCTCTGCT CTCCATCCTGGGCGGCATCTGTGTCTTCTCCACCTGCTGCTGTGACTCCAAGGAGGACCCAGCCACCAGGGTGGGACTTCCCTACAAGCCTTCTACGGTTGTGACAGCCCGAGCCACTTCCGATGAAA GTGACGTCAGCTTTGGTAAATATGGCAAAAATGCCTACGTGTAG
hide sequence
RefSeq Acc Id:
XM_006249155 ⟹ XP_006249217
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 25,334,849 - 25,345,104 (-) NCBI mRatBN7.2 12 19,698,169 - 19,708,419 (-) NCBI Rnor_6.0 12 22,738,198 - 22,750,392 (-) NCBI Rnor_5.0 12 24,749,982 - 24,759,973 (-) NCBI
Sequence:
TTCCTCCCCTATCCTGAAACCACTTCGAAGGAACAAGGAACCTCGAGGACGTGGCTTTTCCACT GCCCCAGAATCATGAGAGAGAACAGTGAACAGGAGGGACTGCAAGCTGGGATTTATGACTCTGGTCTCCTCTGACCCACACAGCTGCCTGGGAGTTTTCCACTGCAGGGGGCCCCCACTGGGCTTCCT CCAAAAACCTCCGCCCTTCCCTCCCTTTGTCTTCCTTCCCCCTCCCCTTCCTCTGCCCCGTCTTTCTCCTTTCGGGGGACATGGATGACGTAGGGTGAGAGCGGAAGCTGTGGAGATGGCAGGGGTGA TGGGGGTTGTTGGGCACAGGATACCCCAGTCCCAGCCTGTGGGGTGGGAGGCAGAGATCTCACAGAGCTCACCCCACACCCCTGTGCCAGGCTCTGCGTGGGCCTGTTTGGCTTCCCTGCATTCTTGT CATTCCACAGCCCCTGGCAGGCTGGCTGAGGGGTGGGAGGAGGTACCTGAGGGGAACATGGAGAAGCTGCATTCAGAAAAAGGGGATGGGGACCCACAGTGGGCAGAGTCGTGGCTCGCACACTCAGG AAAGGGAGCCTAGGGCCAACTTGCCAAGCAAGACCAGGAAGCAGCCAAGAAGGGAATGTGTGTTCAGACAGGTGCTTGGCTAGGGTTGGGGTGGGGAACCCAGAGGTTTCCAGTTATCATAATTAATA GAGCTGGTAATGGTTCCCAATAAGTGGACAGGTAGAGAGATTAGCCAGAACCATGCCTTAGACTTATAATCAGCCCCCCACCCTGGGCCCCTGGCCCCTTGGCAGGAAGATCAAACTCAAGTGCCGAA GAGTCAAAGGTCAGCCGGAGGGGCAATTCAAGTTCAGGAAGTTTGGAGGAAAGTAGTATTCGGTGGCCTCACCTCAGCCCTGCAGCATTTAAATCCAAGCAACCGATAGAGCCATGGGAGTGTGCCCA GGAGCTATGATCTGTGGTCCCAACTCCCATTACAACCCCAAAGCCAATAATGGTTGTGTCAACAAAGCCAACAGCCAGAGACTAAAGCCCAGGGCCCTATGATATCTGGAGTCCAGTGGGAGCCAGGT TGGCAGGGTCTGAGAGGTCCTGTCACCCCCAACTCAAACTTGATGGTCCCTGGAGATTTATGTGTCCCATCTGTAGGGTCTTCAGCATCCTAGGTTGCTCGTCGTGGAAGGCTGTGGTGGGCCTGGTG GAAGGAAGTTTTCTTCTCTAGACACTCTGGTCTTTTGGGTACTAAAACTCTTTGTCCCTCTAATTTCATTCCCTGACCCTGGTGACAGCTGAGTCAGAGACAGGCTACTTCCCCTGGATTCCTAATGC CTCCCTTGGGGGCTGCTCCTTGGCTGTATCCATAAGTCTCCCACCAACAGCTGCAGAGCGGAGCAGGCTTGGCTCATTCCTCTGACCTGCCAGGAAGCAGAGCCTCCCAGAGACCGGGCAGAAGCAAT CAGACCTGACCTCCAGAAGACAGCAGACAAGAACCGCAGCTGGATGAGCTTCCCTTCAACCTTCTCCCTCCTCAGTCTTCCTTAGCATCTCACCTGGAGGAGCCACCTCTATCCCAATCCCTGGGGCT CAAGCCCCCTTGCGGGACCTGCATCCCAGCATGTCGATAGCTGTGGAGACCTTTGGTTTCTTCATGTCAGCCCTGGGACTGCTGATGCTGGGGGTGACCCTTCCAAACAGCTACTGGAGAGTGTCTAC CGTCCATGGGAACGTCATCACCACTAACACCATCTTCGAGAACCTGTGGTACAGCTGTGCCACCGACTCCCTGGGAGTCTCCAACTGCTGGGACTTCCCGTCCATGCTGGCCCTCTCTGGCTATGTCC AGGGCTGCCGAGCTCTCATGATCACCGCCATCCTCCTGGGCTTCCTGGGCCTCTTTCTAGGCATGGTGGGGCTCCGCTGCACCAACGTGGGCAACATCGACCTCTCCAGAAAGGCCAAGCTGCTGGCC ATTGCAGGGGCCTTCCACATACTTGCTGGAGCCTGTGGCATGGTTGCTATCTCATGGTATGCTGTCAACATCACCACCGACTTCTTCAACCCCCTGTATGTTGGAACCAAGTATGAACTGGGCTCTGC CCTCTACTTGGGCTGGAGCGCCTCTCTGCTCTCCATCCTGGGCGGCATCTGTGTCTTCTCCACCTGCTGCTGTGACTCCAAGGAGGACCCAGCCACCAGGGTGGGACTTCCCTACAAGCCTTCTACGG TTGTGACAGCCCGAGCCACTTCCGATGAAAGTGACGTCAGCTTTGGTAAATATGGCAAAAATGCCTACGTGTAGGAGCTCCGGCCTGGTGGACAGCGTTTCTTGTCCCACTGTCCCCAGCAGAAAACG TCCCCAGGACCTGTGGGAGGACTAGTCTCCAGTTAATAACCTGAGGACAGGCCAAATTTCCAGGCCTCAGCCTATGCCGGGAAGCCACTACCCACTCTGGGCACACCTTATCTGGCACTCCAGTCTCT CCCAGGAACAGAAGCTTCAGGGGCAACTTGCATGGCCTCCCACAGCTGGACTCAAGGGGACAGAGGTGTCTGCAGCATGTGACTCTATAGAAATATGTGCATAAATCAATGTATATTGTGATTGTACA GGGGGCTCCTGGGGTCCTGAAGTTACGACCACGGAAGGGGGTCATTTTCAAGCCATAGACTGTCAAGTCTGCCCACTTTGGGGGCTGTGTCATCTAGTGAGACGGTGGGCCAGGGAGCTGGGGACGTG GCTCAGTGAGTTTAGAGTGTTTGCTACACAAGTATGAGGACCTGAGTTCAAATCCCCAGTACCCGTGTGAAAAGCGGGCCCTGGACACACTCCTGCAGCCCAAGTGTTGCTAGGGAGGGGCTCTGAGG CTCACTGGCTTCCAACCTCACTCCAGGTTCTATGTGAGTTCAATCTCAAGGGAATGAGGTGGAGCACGATAGAGCAGGGTGCTGGGAGCCCTCTTCCGACCTTTGCGGGCACACAGACTTGTGCGTAG AGGACACACGCGTGCGCGCACACACACACACACACACATTCTCAATAAAAGGATTTGAAAGGGGGAAATCGCTAACAACTGCTCCGAATCACCCACCTCAGGAGACTGTTAATAGCTGGGAAGCTTCT GGCCCACTGAAAGTTCCTCTCTGTTGACCCCTGACCTATTTTCTCACAGCCTCACAAAGGGGCAGTTGATTTAGAACGGGCGGGCATTGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG TGTGTGTGTGTGTGTGTGTGTGTTTAAAGTCGATTTGGGGTTTAAAATAAAGGTTTTTTTTTTTTGGTTCTTTTTTTCGGAGCTGGGGACCGAACCCAGGGCCTTGCGCTTCCCAGGCAAGCGCTCTA CCACTGAGCTAAATCCCCAACCCCAAAATAAAGGTATTTTTAAAGATG
hide sequence
RefSeq Acc Id:
NP_001100605 ⟸ NM_001107135
- UniProtKB:
D3ZQJ0 (UniProtKB/Swiss-Prot)
- Sequence:
MSIAVETFGFFMSALGLLMLGVTLPNSYWRVSTVHGNVITTNTIFENLWYSCATDSLGVSNCWDFPSMLALSGYVQGCRALMITAILLGFLGLFLGMVGLRCTNVGNIDLSRKAKLLAIAGAFHILAG ACGMVAISWYAVNITTDFFNPLYVGTKYELGSALYLGWSASLLSILGGICVFSTCCCDSKEDPATRVGLPYKPSTVVTARATSDESDVSFGKYGKNAYV
hide sequence
RefSeq Acc Id:
XP_006249217 ⟸ XM_006249155
- Peptide Label:
isoform X1
- UniProtKB:
D3ZQJ0 (UniProtKB/Swiss-Prot)
- Sequence:
MSIAVETFGFFMSALGLLMLGVTLPNSYWRVSTVHGNVITTNTIFENLWYSCATDSLGVSNCWDFPSMLALSGYVQGCRALMITAILLGFLGLFLGMVGLRCTNVGNIDLSRKAKLLAIAGAFHILAG ACGMVAISWYAVNITTDFFNPLYVGTKYELGSALYLGWSASLLSILGGICVFSTCCCDSKEDPATRVGLPYKPSTVVTARATSDESDVSFGKYGKNAYV
hide sequence
Ensembl Acc Id:
ENSRNOP00000001923 ⟸ ENSRNOT00000001923
RGD ID: 13698531
Promoter ID: EPDNEW_R9055
Type: initiation region
Name: Cldn15_1
Description: claudin 15
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 12 22,748,873 - 22,748,933 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Cldn15
claudin 15
Cldn15_predicted
claudin 15 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Cldn15_predicted
claudin 15 (predicted)
Symbol and Name status set to approved
70820
APPROVED